These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 9878048)
1. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048 [TBL] [Abstract][Full Text] [Related]
2. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations. Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases. Manns JM; Brenna KJ; Colman RW; Sheth SB Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792 [TBL] [Abstract][Full Text] [Related]
4. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant. Eckert RE; Jones SL J Leukoc Biol; 2007 Nov; 82(5):1311-21. PubMed ID: 17684042 [TBL] [Abstract][Full Text] [Related]
5. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. Bilodeau ML; Hamm HE J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299 [TBL] [Abstract][Full Text] [Related]
6. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport. Borgognone A; Pulcinelli FM Thromb Haemost; 2012 Nov; 108(5):955-62. PubMed ID: 23014861 [TBL] [Abstract][Full Text] [Related]
7. Human cyclic GMP-dependent protein kinase I beta overexpression increases phosphorylation of an endogenous focal contact-associated vasodilator-stimulated phosphoprotein without altering the thrombin-evoked calcium response. Meinecke M; Geiger J; Butt E; Sandberg M; Jahnsen T; Chakraborty T; Walter U; Jarchau T; Lohmann SM Mol Pharmacol; 1994 Aug; 46(2):283-90. PubMed ID: 8078490 [TBL] [Abstract][Full Text] [Related]
8. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Hauser W; Knobeloch KP; Eigenthaler M; Gambaryan S; Krenn V; Geiger J; Glazova M; Rohde E; Horak I; Walter U; Zimmer M Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8120-5. PubMed ID: 10393958 [TBL] [Abstract][Full Text] [Related]
9. Age-related decrease of protein kinase G activation in vascular smooth muscle cells. Lin CS; Liu X; Tu R; Chow S; Lue TF Biochem Biophys Res Commun; 2001 Sep; 287(1):244-8. PubMed ID: 11549281 [TBL] [Abstract][Full Text] [Related]
10. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase. Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631 [TBL] [Abstract][Full Text] [Related]
11. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change. Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F Platelets; 2011; 22(1):8-19. PubMed ID: 20958117 [TBL] [Abstract][Full Text] [Related]
12. Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets. Benz PM; Laban H; Zink J; Günther L; Walter U; Gambaryan S; Dib K Cell Commun Signal; 2016 Sep; 14(1):21. PubMed ID: 27620165 [TBL] [Abstract][Full Text] [Related]
13. Distribution, cellular localization, and postnatal development of VASP and Mena expression in mouse tissues. Gambaryan S; Hauser W; Kobsar A; Glazova M; Walter U Histochem Cell Biol; 2001 Dec; 116(6):535-43. PubMed ID: 11810195 [TBL] [Abstract][Full Text] [Related]
14. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387 [TBL] [Abstract][Full Text] [Related]
15. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473 [TBL] [Abstract][Full Text] [Related]
16. [Roles of vasodilator-stimulated phosphoprotein in the regulation of cytoskeleton]. Wang TT; Li K; Wei L Sheng Li Ke Xue Jin Zhan; 2006 Jan; 37(1):27-30. PubMed ID: 16683541 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440 [TBL] [Abstract][Full Text] [Related]
19. Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells. Wang X; Pluznick JL; Settles DC; Sansom SC Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1768-76. PubMed ID: 17913834 [TBL] [Abstract][Full Text] [Related]
20. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation. Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]